A systematic review on the role of MSC-derived exosomal miRNAs in the treatment of heart failure

被引:8
作者
Botello-Flores, Yesica Abril [1 ,2 ]
Yocupicio-Monroy, Martha [2 ]
Balderrabano-Saucedo, Norma [3 ]
Contreras-Ramos, Alejandra [1 ]
机构
[1] Childrens Hosp Mexico Federico Gomez HIMFG, Lab Dev Biol Res & Expt Teratogen, Dr Marquez 162, Mexico City 06720, DF, Mexico
[2] Autonomous Univ Mexico City, Postgrad Genom Sci, Mexico City, DF, Mexico
[3] Childrens Hosp Mexico Federico Gomez HIMFG, Res Lab Cardiomyopathies & Arrhythmias, Mexico City, DF, Mexico
关键词
Systematic review; Heart failure; Heart diseases; Biomarkers; miRNAs; MSCs; Exosomal; MESENCHYMAL STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; HUMAN ADIPOSE-TISSUE; SIGNAL TRANSDUCER; REPERFUSION INJURY; OXIDATIVE STRESS; ACTIVATOR; CARDIOMYOCYTES; APOPTOSIS; CARDIOMYOPATHY;
D O I
10.1007/s11033-022-07385-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background This systematic review summarizes results of studies that evaluated the expression of microRNAs (miRs) in pre-diabetes or type 2 diabetes. Methods The information was obtained in PubMed, EMBL-EBI, Wanfang, Trip Database, Lilacs, CINAHL and Google. A qualitative synthesis of the results was performed and miRs frequency was graphically. From 1880 we identified studies, only 53 fulfilled the inclusion criteria. The 53 studies analyzed miRs in T2D; and of them, thirteen also described data in pre-diabetes. Results In diabetics, 122 miRs were reported and 35 miRs for pre-diabetics. However, we identified that 5 miRs (-122-5p, 144-3p, 210, 375, -126b) were reported more often in diabetics, and 4 (144-3p, -192, 29a and -30d) in pre-diabetics. Conclusions Circulating miRs could be used as biomarkers of type 2 diabetes. However, it is necessary to validate these microRNAs in prospective and multi-center studies, where different population subgroups, considering the age, gender, and risk factors.
引用
收藏
页码:8953 / 8973
页数:21
相关论文
共 91 条
[1]   Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF) [J].
Akers, Johnny C. ;
Ramakrishnan, Valya ;
Nolan, John P. ;
Duggan, Erika ;
Fu, Chia-Chun ;
Hochberg, Fred H. ;
Chen, Clark C. ;
Carter, Bob S. .
PLOS ONE, 2016, 11 (02)
[2]   Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species [J].
Baglio, Serena Rubina ;
Rooijers, Koos ;
Koppers-Lalic, Danijela ;
Verweij, Frederik J. ;
Lanzon, M. Perez ;
Zini, Nicoletta ;
Naaijkens, Benno ;
Perut, Francesca ;
Niessen, Hans W. M. ;
Baldini, Nicola ;
Pegtel, D. Michiel .
STEM CELL RESEARCH & THERAPY, 2015, 6
[3]   Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges [J].
Bagno, Luiza ;
Hatzistergos, Konstantinos E. ;
Balkan, Wayne ;
Hare, Joshua M. .
MOLECULAR THERAPY, 2018, 26 (07) :1610-1623
[4]   Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome [J].
Balbi, Carolina ;
Lodder, Kirsten ;
Costa, Ambra ;
Moimas, Silvia ;
Moccia, Francesco ;
van Herwaarden, Tessa ;
Rosti, Vittorio ;
Campagnoli, Francesca ;
Palmeri, Agnese ;
De Biasio, Pierangela ;
Santini, Francesco ;
Giacca, Mauro ;
Goumans, Marie-Jose ;
Barile, Lucio ;
Smits, Anke M. ;
Bollini, Sveva .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 287 :87-95
[5]   Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]) [J].
Bartolucci, Jorge ;
Verdugo, Fernando J. ;
Gonzalez, Paz L. ;
Larrea, Ricardo E. ;
Abarzua, Ema ;
Goset, Carlos ;
Rojo, Pamela ;
Palma, Ivan ;
Lamich, Ruben ;
Pedreros, Pablo A. ;
Valdivia, Gloria ;
Lopez, Valentina M. ;
Nazzal, Carolina ;
Alcayaga-Miranda, Francisca ;
Cuenca, Jimena ;
Brobeck, Matthew J. ;
Patel, Amit N. ;
Figueroa, Fernando E. ;
Khoury, Maroun .
CIRCULATION RESEARCH, 2017, 121 (10) :1192-+
[6]   Inflammation-associated microRNA changes in circulating exosomes of heart failure patients [J].
Beg F. ;
Wang R. ;
Saeed Z. ;
Devaraj S. ;
Masoor K. ;
Nakshatri H. .
BMC Research Notes, 10 (1)
[7]   miR-210: The Master Hypoxamir [J].
Chan, Yuk C. ;
Banerjee, Jaideep ;
Choi, Sang Yong ;
Sen, Chandan K. .
MICROCIRCULATION, 2012, 19 (03) :215-223
[8]   Preservation of exosomes at room temperature using lyophilization [J].
Charoenviriyakul, Chonlada ;
Takahashi, Yuki ;
Nishikawa, Makiya ;
Takakura, Yoshinobu .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 553 (1-2) :1-7
[9]   Bone marrow mesenchymal stem cell-secreted exosomes carrying microRNA-125b protect against myocardial ischemia reperfusion injury via targeting SIRT7 [J].
Chen, Qi ;
Liu, Yu ;
Ding, Xueyan ;
Li, Qinfeng ;
Qiu, Fuyu ;
Wang, Meihui ;
Shen, Zhida ;
Zheng, Hao ;
Fu, Guosheng .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2020, 465 (1-2) :103-114
[10]   Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis [J].
Cheng, Hao ;
Chang, Shufu ;
Xu, Rende ;
Chen, Lu ;
Song, Xiaoyue ;
Wu, Jian ;
Qian, Juying ;
Zou, Yunzeng ;
Ma, Jianying .
STEM CELL RESEARCH & THERAPY, 2020, 11 (01)